Flagellin-based polypeptides for the diagnosis of lyme disease

Details Flagellin-based polypeptides for the diagnosis of lyme disease Flagellin-based polypeptides for the diagnosis of lyme disease

1993-12-10

1997-04-08

Housel, James C.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

530350, 530300, 530825, 5303875, 435 13, 435197, 435 11, 435192, 435132, 435975, 536 234, 436536, 436347, 436548, 436800, C07K 500, C07H 2104, C12N 1500, G01N 33536

Patent

active

056185332

ABSTRACT:
Diagnostic means and methods for Lyme disease comprising B. burgdorferi flagellin polypeptides and antibodies. Compositions and methods comprising neuroborreliosis-associated antigens useful for the detection, treatment and prevention of neuroborreliosis, arthritis, carditis and other manifestations of Lyme disease.

REFERENCES:
patent: 5187065 (1993-02-01), Schutzer
Steere, A.C. (89) New Engl. J. Med. 324: 586-596.
Grodeicki, R.L. et al (88) J. Inf. Dis. 157:790-797.
Coleman, J.L. et al. (87) J. Inf. Dis. 155:756-765.
Wallich, R. et al (90) Inf. Imm. 58:1711-1719.
Gassman, G.S. et al. (91) J. Bacteriol. 173:1452-1459.
Berland, R. et al (91) Inf. Imm. 59:3531-3535.
Rasiah, C. et al. (92) J. Gen. Microbiol. 138-147-154.
E. Aberr et al., "Molecular Mimicry and Lyme Borreliosis: A Shared Antigenic Determinant Between Borrelia burgdorferi and Human Tissue", Ann. Neurol., 26, pp. 732-737 (1989).
A.G. Barbour et al., "A Borrelia-Specific Monoclonal Antibody Binds to a Flagellar Epitope", Infec. Immun., 52, pp. 549-554.
R. Berland et al., "Molecular Characterization of the Humoral Response to the 41-Kilodalton Flagellar Antigen of Borrelia burgdorferi, the Lyme Disease Agent", Infect. Immun., 59, pp. 3531-3535 (1991).
J.L. Coleman and J.L. Benach, "Isolation of Antigenic Components from the Lyme Disease Spirochete: Their Role in Early Diagnosis", J. Infect. Dis., 155, pp. 756-765 (1987).
J.L. Coleman and J.L. Benach, "Identification and Characterization of an Endoflagellar Antigen of Borrelia burgdorferi", J. Clin. Invest., 84, pp. 322-330 (1989).
C. Collins nd G. Peltz, "Immunoreactive Epitopes on an Expressed Recombinant Flagellar protein of Borrelia burgdorferi", Infect. Immun., 59, pp. 514-520 (1991).
J.E. Craft et al., "Antibody Response in Lyme Diseade: Evaluation of Diagnostic Tests", J. Infec. Dis., 149, pp. 789-795 (1984).
J.E. Craft et al., "Antigens Of Borrelia burgdorferi Recognized during Lyme Disease", J. Clin. Invest., 78, pp. 934-939 (1986).
G.S. Gassmann et al., "Analysis of the Borrelia burgdorferi GeHo Antigenic Charachterization of Its Gene Product", J. Bacteriol., 173, pp. 1452-1459 (1991).
G.S. Gassmann et al., "Nucleotide sequence of a gene encoding the borrelia burgdorferi flagellin", Nuc. Acids Res., 17, p. 3590 (1989).
R.L. Grodzicki and A.C. Steere, "Compariosn of Immunoblotting and Indirect Enzyme-Linked Immunosorbent Assay Using Different Antigen Prepara tions for Diagnosing Early Lyme Disease", J. Inf. Dis., 157, pp. 790-797 (1988).
K. Hansen et al., "Measurement of Antibodies to the Borrelia burgdorferi Flagellum Improves Serodiagnosis in Lyme Disease", J. Clin. Microbiol., 26, pp. 338-346 (1988).
M.D. Kramer et al., "Characterization of Borrelia burgdorferi Associated Antigens by Monoclonal Antibodies", Immunobiol., 181, pp. 357-366 (1990).
B.J. Luft et al., "Biochemical and Immunological Characterization of the Surface Proteins of Borrelia burgdorferi", Infect. Immun., 57, pp. 3637-3645 (1989).
S.W. Luger and E. Krauss, "Serologic Tests for Lyme Disease: Interlaboratory Variability", Arch. Intern. Med., 150, pp. 761-763 (1990).
L.A. Magnarelli et al., "Cross-Reactibity in Serological Tests for Lyme Disease and other Spirochetal Infections", J. Infect. Dis., 156, pp. 183-188 (1987).
L.A. Magnarelli etal., "Cross-Reactivity of Nonspecific Treponemal Antibody in Serologic Tests for Lyme Disease", J. Clin. Microbiol., 28, pp. 1276-1279 (1990).
L. H. Sigal and A.H. Tatum, "Lyme disease patients serum contains igM antibodies to Borrelia burdorferi that cross-react with neuronal antigens", Neurology, 38, pp. 1439-1442 (1988).
R. Wallich et al., "The Borrelia burgdorferi Flagellum-Associated 41-Kilodalton Antigen (Flagellin): Molecular Cloning, Expression and Amplification of the Gene". Infect. Immun., 58, pp. 1711-1719 (1990).
Weiner, H.L. et al. (1991) Ann. Y Acad. Sci. 636-227-232.
Schneider, T. et al. (1991) Inf. Immun. 60:316-319.
Kumar et al. 1990. Amino Acid Variahons at a single residue in an autoimmune peptide profoundly affect . . . PNAS 87: 1337-41.
Steere 1989. Medical Progress: Lyme Disease New England J. of Medicine 321(9):586-596.
Gassman et al. 1990 "Molecular Analysis of Borrelia Burdorferi Flagllin". IV International Conference on Lyme Borrelions Abstract W-L-5 p6.
Houghten et al. 1986. Relative Importance of position and Individual amino acid . . . in Vaccines 86 d. Brown et al. pp. 21-25.
G.S. Gassman et al., "Molecular Analysis of the Borrelia Burgdorferi Flagellin," IV International Conference on Lyme Borreliosis, Abstract W-L-5, p. 6, Stockholm, Sweden (1990).

Affiliated with

Also associated with

Rating

Flagellin-based polypeptides for the diagnosis of lyme disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Flagellin-based polypeptides for the diagnosis of lyme disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flagellin-based polypeptides for the diagnosis of lyme disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2396398